Stay updated with breaking news from Medicines Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Collaboration and knowledge sharing amongst rare disease researchers can be difficult, as these researchers are often spread out throughout the world.
The CMA acts to help NHS patients access combination therapies used to treat serious medical conditions.
The Competition and Markets Authority (CMA) has today issued a statement clarifying that certain types of engagements between competing drug firms working on 'combination therapies' will not be prioritized for investigation - making it easier for drug firms to work together to develop vital treatments for use in the NHS.
(CTN News) - A drug used to treat advanced lymphoma has been recommended by the National Institute for Health and Care Excellence..........
An oral small molecule CGRP antagonist has been recommended for episodic migraines in NICE final draft guidance.